United States Public Health Service bicentennial 1798-1998: A focus on oncology pharmacy practice at the National Institutes of Health

Abstract

Get full access to this article

View all access options for this article.

References

Kinsey RD , Archambault GF , Foster TA Pharmacy in the US Public Health Service: then and now. J Am Pharm Assoc. 1948 ;9:345-347, 376, 378, 380, 383-384.

The Commissioned Corps of the United States Public Health Service: Health Leadership in a Time of Change. Washington, DC: Commissioned Officers Association of the United States Public Health Service; March, 1993.

Moore SR , Abramek FJ The US Public Health Service Commissioned Corps pharmacist: the evolution of professional practice. Pharmacy in History. 1992;34:110-115.

Furman B. A Profile of the United States Public Health Service 1798-1948. Washington, DC: Dept of Health, Education, and Welfare; 1973. Publication 73-369.

Paavola FG , Dermanoski K. , Pittman R. Pharmaceutical services in the United States Public Health Service. Am J Health Syst Pharm. 1997;54:766-772.

Zimmerman PF , Larsen RK , Barkley EW , Gallelli JF Recommendations for the safe handling of injectable antineoplastic drug products. Am J Hosp Pharm. 1981;38:1693-1695.

Vaccari PL , Tonat K. , DeChristoforo R. , Gallelli JF , Zimmerman PF Disposal of antineoplastic wastes at the National Institutes of Health. Am J Hosp Pharm. 1984;41:87-93.

US Dept of Health and Human Services , Public Health Service, Washington, DC: National Institutes of Health; 1992. NIH Publication 92-2621.

Kohler DR , Montello MJ , Green L. , Huntley C. , High JL , Fallavollita A. , Goldspiel BR Standardizing the expression and nomenclature of can- cer treatment regimens . Am J Health Syst Pharm. 1998; 55:137-144.

10.

DeCederfelt HJ , Grimes GJ , Green L. , DeCederfelt RO , Daniels CE Handling of gene-transfer products by the National Institutes of Health Clinical Center pharmacy department. Am J Health Syst Pharm. 1997; 54:1604-1610.

11.

Montello MJ , Greenblatt JJ , Fallavollita A. , Shoemaker D. Accessing investigational anticancer agents outside of clinical trials. Am J Health Syst Pharm. 1998;55:651-652, 660.

12.

McIntosh H. 25 years ahead: will cancer be a "background-noise kind of disease"? J Natl Cancer Inst. 1996 ; 88:1794-1798.